Large animal models of pressure overload-induced cardiac left ventricular hypertrophy to study remodeling of the human heart with aortic stenosis.
Evangelia BeslikaAdelino Leite-MoreiraLeon J De WindtPaula A da Costa MartinsPublished in: Cardiovascular research (2024)
Pathologic cardiac hypertrophy is a common consequence of many cardiovascular diseases, including aortic stenosis. Aortic stenosis is known to increase the pressure load of the left ventricle, causing a compensative response of the cardiac muscle, which progressively will lead to dilation and heart failure. In a cellular level, this corresponds to a considerable increase in the size of cardiomyocytes, named cardiomyocyte hypertrophy, as their proliferation capacity is attenuated upon the first developmental stages. Cardiomyocytes, in order to cope with the increased workload (overload), suffer alterations in their morphology, nuclear content, energy metabolism, intracellular homeostatic mechanisms, contractile activity and cell death mechanisms. Moreover, modifications in the cardiomyocyte niche, involving inflammation, immune infiltration, fibrosis and angiogenesis, contribute to the subsequent events of a pathologic hypertrophic response. Considering the emerging need for a better understanding of the condition and treatment improvement, as the only available treatment option of aortic stenosis consists of surgical interventions at a late stage of the disease, when the cardiac muscle state is irreversible, large animal models have been developed to mimic the human condition, to the greatest extend. Smaller animal models lack physiology and cellular and molecular mechanisms that sufficiently resemblance humans; in vitro techniques yet fail to provide adequate complexity. Animals, such as the ferret (Mustello purtorius furo), lapine (rabbit, Oryctolagus cunigulus), feline (cat, Felis catus), canine (dog, Canis lupus familiaris), ovine (sheep, Ovis aries) and porcine (pig, Sus scrofa), have contributed to the research by elucidating implicated cellular and molecular mechanisms of the condition. Essential discoveries of each model are reported and discussed briefly in this review. Results of large animal experimentation could further be interpreted aiming to the prevention of the disease progress or, alternatively, to the regression of the implicated pathologic mechanisms to a physiologic state. This review summarizes the important aspects of the pathophysiology of LV hypertrophy and the applied surgical large animal models that better mimic the condition until the present moment.
Keyphrases
- aortic stenosis
- left ventricular
- heart failure
- aortic valve replacement
- endothelial cells
- transcatheter aortic valve replacement
- high glucose
- transcatheter aortic valve implantation
- ejection fraction
- aortic valve
- cardiac resynchronization therapy
- hypertrophic cardiomyopathy
- mitral valve
- acute myocardial infarction
- cell death
- neoadjuvant chemotherapy
- left atrial
- skeletal muscle
- coronary artery disease
- cardiovascular disease
- systemic lupus erythematosus
- oxidative stress
- locally advanced
- metabolic syndrome
- angiotensin ii
- squamous cell carcinoma
- vascular endothelial growth factor
- acute heart failure
- physical activity
- pulmonary artery
- coronary artery
- rheumatoid arthritis
- atrial fibrillation
- liver fibrosis
- diabetic rats
- radiation therapy
- lymph node
- pulmonary hypertension
- pulmonary arterial hypertension